Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

NHS National Framework for Transition products commencing 1 October 2024

  • First published: 22 October 2024
  • Last modified: 22 October 2024
  • Record interest

     

  • This file may not be fully accessible.

  •  

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
ocds-h6vhtk-0472c3
Published by:
NHS England
Authority ID:
AA20005
Publication date:
22 October 2024
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

Project title: NHS National Framework for Transition products commencing 1 October 2024<br/>Offer reference number: CM/TNS/24/5712<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/> <br/>CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) <br/><br/>CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) <br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

NHS England

7-8 Wellington Place

Leeds

LS1 4AP

UK

Contact person: Katie Noonan

E-mail: katie.noonan@nhs.net

NUTS: UK

Internet address(es)

Main address: https://www.england.nhs.uk/

Address of the buyer profile: https://www.england.nhs.uk/

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.4) Type of the contracting authority

Ministry or any other national or federal authority, including their regional or local subdivisions

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

NHS National Framework for Transition products commencing 1 October 2024

Reference number: CM/TNS/24/5712

II.1.2) Main CPV code

33600000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

Project title: NHS National Framework for Transition products commencing 1 October 2024<br/>Offer reference number: CM/TNS/24/5712<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/> <br/>CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) <br/><br/>CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) <br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

II.1.6) Information about lots

This contract is divided into lots: Yes

II.1.7) Total value of the procurement

Value excluding VAT: 44 215 000.00  GBP

II.2) Description

Lot No: 1

II.2.1) Title

CM/TNS/24/5712/01

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months)

II.2.5) Award criteria

Price

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

II.2.14) Additional information

CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months)

Lot No: 2

II.2.1) Title

CM/TNS/24/5712/02

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

II.2.4) Description of the procurement

CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months)

II.2.5) Award criteria

Price

II.2.11) Information about options

Options: Yes

Description of options:

Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

II.2.14) Additional information

CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months)

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2024/S 000-019556

Section V: Award of contract

Lot No: 1

Title: Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

30/09/2024

V.2.2) Information about tenders

Number of tenders received: 25

Number of tenders received from SMEs: 14

Number of tenders received from tenderers from EU Member States: 25

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 25

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Thornton and Ross Ltd

00185947

Thornton & Ross Linthwaite Laboratories, Manchester Road, Linthwaite,

Huddersfield

HD7 5QH

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 1

Title: Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

30/09/2024

V.2.2) Information about tenders

Number of tenders received: 25

Number of tenders received from SMEs: 14

Number of tenders received from tenderers from EU Member States: 25

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 25

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Tillomed Laboratories ltd

2544103

Tillomed Laboratories ltd 220 Butterfield Great Marlings

Luton

LU2 8DL

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 1

Title: Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

30/09/2024

V.2.2) Information about tenders

Number of tenders received: 25

Number of tenders received from SMEs: 14

Number of tenders received from tenderers from EU Member States: 25

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 25

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Glenmark Pharmaceuticals Europe Limited

5040260

Glenmark Pharmaceuticals Europe Limited 2-B Laxmi House, Draycott Avenue Kenton,

Harrow, Middlesex,

HA3 0BU

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 1

Title: Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

30/09/2024

V.2.2) Information about tenders

Number of tenders received: 25

Number of tenders received from SMEs: 14

Number of tenders received from tenderers from EU Member States: 25

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 25

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Gilead Sciences Limited

02543818

Gilead Sciences LTD 280 High Holborn,

London

WC1V 7EE

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 1

Title: Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

30/09/2024

V.2.2) Information about tenders

Number of tenders received: 25

Number of tenders received from SMEs: 14

Number of tenders received from tenderers from EU Member States: 25

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 25

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Amarox Limited

10997632

Amarox Limited Congress House, 14 Lyon Road, Harrow,

Middlesex

HA1 2EN

UK

NUTS: UK

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 1

Title: Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

30/09/2024

V.2.2) Information about tenders

Number of tenders received: 25

Number of tenders received from SMEs: 14

Number of tenders received from tenderers from EU Member States: 25

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 25

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Mercury Pharmaceuticals Limited

02619880

Mercury Pharmaceuticals Limited Dashwood House, 69 Old Broad Street,

London,

EC2M 1QS

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 1

Title: Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

30/09/2024

V.2.2) Information about tenders

Number of tenders received: 25

Number of tenders received from SMEs: 14

Number of tenders received from tenderers from EU Member States: 25

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 25

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Teva UK Limited

00302461

Teva UK Ridings Point, Whistler Drive,

Castleford,

WF10 5HX

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 1

Title: Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

30/09/2024

V.2.2) Information about tenders

Number of tenders received: 25

Number of tenders received from SMEs: 14

Number of tenders received from tenderers from EU Member States: 25

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 25

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Zentiva Pharma UK Ltd

2158996

Zentiva Pharma UK Limited 12 New Fetter Lane,

London

EC4A 1JP

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 1

Title: Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

30/09/2024

V.2.2) Information about tenders

Number of tenders received: 25

Number of tenders received from SMEs: 14

Number of tenders received from tenderers from EU Member States: 25

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 25

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Accord-UK Ltd

00079585

Accord-UK Ltd Whiddon Valley,

Barnstaple, Devon,

EX32 8NS

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 1

Title: Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

30/09/2024

V.2.2) Information about tenders

Number of tenders received: 25

Number of tenders received from SMEs: 14

Number of tenders received from tenderers from EU Member States: 25

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 25

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Dr.Reddy's Laboratories (UK) Limited

1729064

Dr.Reddy's Laboratories (UK) Ltd 410, Cambridge Science Park Milton Rd, Milton,

Cambridge

CB4 0PE

UK

NUTS: UK

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 1

Title: Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

30/09/2024

V.2.2) Information about tenders

Number of tenders received: 25

Number of tenders received from SMEs: 14

Number of tenders received from tenderers from EU Member States: 25

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 25

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Celix Pharma Ltd.

12474195

Celix Pharma Ltd. 12 Constance Street, International House,

London

E16 2DQ

UK

NUTS: UK

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 1

Title: Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

30/09/2024

V.2.2) Information about tenders

Number of tenders received: 25

Number of tenders received from SMEs: 14

Number of tenders received from tenderers from EU Member States: 25

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 25

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Seacross Pharmaceuticals Ltd

07650983

Seacross Pharmaceuticals Ltd. Stanmore Business & Innovation Centre, Stanmore Place,

London

UK

NUTS: UK

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 2

Title: Imatinib Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

30/09/2024

V.2.2) Information about tenders

Number of tenders received: 6

Number of tenders received from SMEs: 4

Number of tenders received from tenderers from EU Member States: 6

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 6

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Teva UK Limited

00302461

Teva UK Ridings Point, Whistler Drive,

Castleford,

WF10 5HX

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.4) Procedures for review

VI.4.1) Review body

The High Court

The Strand

London

WC2A 2LL

UK

Internet address(es)

URL: https://www.judiciary.uk/courts-and-tribunals/high-court/

VI.5) Date of dispatch of this notice

17/10/2024

Coding

Commodity categories

ID Title Parent category
33600000 Pharmaceutical products Medical equipments, pharmaceuticals and personal care products

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
katie.noonan@nhs.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.